SVB has cut the price target from $738 to $630 and downgraded from Outperform to Market Perform to reflect Regeneron Pharmaceutical Inc’s (NASDAQ:REGN)…
There are concerns around Snap Inc’s (NYSE: SNAP) revenue and profit outlook, given its disappointing second-quarter results, third-quarter trends so far and certain company-specific challenges, according to Morgan Stanley.
Keefe, Bruyette & Woods analyst Ryan Tomasello downgrades Porch Group (NASDAQ:PRCH) from Outperform to Market Perform and lowers the price target from $5.25 to $3.25.
Keefe, Bruyette & Woods analyst Ryan Tomasello downgrades Latch (NASDAQ:LTCH) from Market Perform to Underperform and lowers the price target from $3.25 to $1.15.
Keefe, Bruyette & Woods analyst Robert Lee downgrades Blackstone (NYSE:BX) from Outperform to Market Perform and lowers the price target from $127 to $115.